Oncogenesis

Papers
(The TQCC of Oncogenesis is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
PELI1 and EGFR cooperate to promote breast cancer metastasis201
Noncanonical PRC1.1 targets BTG2 to retain cyclin gene expression and cell growth in neuroblastoma133
A HOTAIR-associated super-enhancer orchestrates glioblastoma malignancy via MEST69
USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c59
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients57
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC57
NUCKS1 promotes invasion and metastasis of colorectal cancer by stabilizing HDAC2 and activating AKT55
Discovery of neddylation E2s inhibitors with therapeutic activity49
Correction: Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells44
Targeted metabolomics detects a putatively diagnostic signature in plasma and dried blood spots from head and neck paraganglioma patients37
Sphingosine 1-phosphate signalling in cancer stem cells37
Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions31
Spindle function and Wnt pathway inhibition by PBX1 to suppress tumor progression via downregulating DCDC2 in colorectal cancer30
PLEKHA4 is transcriptionally regulated by HOXD9 and regulates glycolytic reprogramming and progression in glioblastoma via activation of the STAT3/SOCS-1 pathway30
P4HB maintains Wnt-dependent stemness in glioblastoma stem cells as a precision therapeutic target and serum marker30
Correction: Mitochondrial dysfunction and impaired growth of glioblastoma cell lines caused by antimicrobial agents inducing ferroptosis under glucose starvation28
Ablation of sphingosine kinase 2 suppresses fatty liver-associated hepatocellular carcinoma via downregulation of ceramide transfer protein27
Breast cancer in the era of integrating “Omics” approaches26
Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies25
Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle24
UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression23
Calreticulin enhances gastric cancer metastasis by dimethylating H3K9 in the E-cadherin promoter region mediating by G9a23
USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer22
STAG2 expression imparts distinct therapeutic vulnerabilities in muscle-invasive bladder cancer cells21
FLT4 activation promotes acute lymphoid leukemia survival through stabilization of MDM2/MDMX and inactivation of p5321
CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia20
Diltiazem inhibits breast cancer metastasis via mediating growth differentiation factor 15 and epithelial-mesenchymal transition20
Preneoplastic cells switch to Warburg metabolism from their inception exposing multiple vulnerabilities for targeted elimination20
PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma19
An E3 ligase TRIM1 promotes colorectal cancer progression via K63-linked ubiquitination and activation of HIF1α19
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma18
NAC1 transcriptional activation of LDHA induces hepatitis B virus immune evasion leading to cirrhosis and hepatocellular carcinoma development17
Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release17
Involvement of Kindlin-1 in cutaneous squamous cell carcinoma17
Collagen type IV alpha 6 promotes tumor progression and chemoresistance in ovarian cancer by activating the discoidin domain receptor 1 pathway17
SLC26A3/NHERF2-IκB/NFκB/p65 feedback loop suppresses tumorigenesis and metastasis in colorectal cancer17
Subtype-specific role for Jagged1 in promoting or inhibiting breast tumor formation16
WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines16
TGF-β signaling redirects Sox11 gene regulatory activity to promote partial EMT and collective invasion of oncogenically transformed intestinal organoids16
Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes16
Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer16
Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy16
NFATc1-mediated activation of the pentose phosphate pathway and cell cycle dysregulation collectively drive tumor progression16
ACT001 inhibited CD133 transcription by targeting and inducing Olig2 ubiquitination degradation15
Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer15
LUBAC promotes angiogenesis and lung tumorigenesis by ubiquitinating and antagonizing autophagic degradation of HIF1α14
HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway14
Correction: Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming14
Correction: Non-enzymatic heparanase enhances gastric tumor proliferation via TFEB-dependent autophagy14
Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy14
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma14
WDR4 promotes the progression and lymphatic metastasis of bladder cancer via transcriptional down-regulation of ARRB214
Correction: TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple13
SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-113
Correction: Tumor-derived exosomes induce PD1+ macrophage population in human gastric cancer that promotes disease progression13
Depletion of NK6 Homeobox 3 (NKX6.3) causes gastric carcinogenesis through copy number alterations by inducing impairment of DNA replication and repair regulation13
Correction: PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma13
CD147-high extracellular vesicles promote gastric cancer metastasis via VEGF/AKT/eNOS and AKT/mTOR pathways13
0.81006193161011